首页> 外国专利> METHOD FOR SCREENING MEDICAMENT USED IN DIAGNOSIS OR TREATMENT OF DISEASE CAUSED BY ABNORMAL ACTIVATION OF MACROPHAGIC CELL

METHOD FOR SCREENING MEDICAMENT USED IN DIAGNOSIS OR TREATMENT OF DISEASE CAUSED BY ABNORMAL ACTIVATION OF MACROPHAGIC CELL

机译:筛选用于巨噬细胞异常激活引起的疾病的诊断或治疗药物的方法

摘要

PROBLEM TO BE SOLVED: To provide a relatively low-molecular peptide usable in screening diagnostics or therapeutic agents for various diseases caused by the abnormal activation of macrophage or microglia. ;SOLUTION: The subject method is characterized by comprising using a compound of the general formula (1):R1-Leu(or Ile)-His-Thr-Leu-R2 [wherein, R1 is a (modifying group-bearing) amino acid residue, (modifying group-bearing) peptide residue, amino acid N-terminal protective group or H atom; R2 is a (modifying group-bearing) amino acid residue, (modifying group-bearing) peptide residue, amino acid C-terminal protective group or H atom; Leu is a leucine residue; Ile is an isoleucine residue; His is a histidine residue; and Thr is a threonine residue].;COPYRIGHT: (C)2001,JPO
机译:要解决的问题:提供一种相对低分子的肽,可用于筛选诊断或治疗剂,以诊断由巨噬细胞或小胶质细胞的异常激活引起的各种疾病。 ;解决方案:该方法的特征在于包括使用通式(1)的化合物:R 1 -Leu(或Ile)-His-Thr-Leu-R 2 [其中,R 1是(带有修饰基团的)氨基酸残基,(带有修饰基团的)肽残基,氨基酸N-末端保护基或H原子; R 2是(带有修饰基团的)氨基酸残基,(带有修饰基团的)肽残基,氨基酸C端保护基或H原子; Leu是亮氨酸残基; Ile是异亮氨酸残基;他是一个组氨酸残基; ,苏氨酸是苏氨酸残基] 。;版权所有:(C)2001,日本特许厅

著录项

  • 公开/公告号JP2001278809A

    专利类型

  • 公开/公告日2001-10-10

    原文格式PDF

  • 申请/专利权人 JAPAN SCIENCE & TECHNOLOGY CORP;

    申请/专利号JP20000094989

  • 发明设计人 NAKAMURA YOICHI;

    申请日2000-03-30

  • 分类号A61K39/395;A61K38/00;A61P25/28;C07K4/00;C07K16/18;C12N5/06;C12Q1/02;G01N33/15;G01N33/50;G01N33/566;

  • 国家 JP

  • 入库时间 2022-08-22 01:28:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号